Vascularized Organ-on-Chip Customization Service Powered CAR-T Development

Unpredictable clinical outcomes, insufficient physiological relevance in conventional preclinical models, and prolonged animal trial timelines remain major bottlenecks in CAR-T development. The Vascularized Organ-on-Chip Customization Service provides an advanced solution to streamline CAR-T evaluation and improve translational decision-making through an engineered "trial-on-chip" platform that faithfully recapitulates human leukemia niches. By leveraging organotypic microphysiological systems with integrated vascular networks, this service enables real-time monitoring of T-cell extravasation, immune activation, and tumor cytotoxicity in a human-relevant microenvironment.

Introduction

Vascularized organ-on-chip platforms integrate microfluidics, 3D tissue constructs, and perfusable microvasculature to emulate human organ-level physiology. Recent academic studies demonstrate that such systems improve prediction of immune cell trafficking and therapeutic response compared with static cultures. Applied to CAR-T research, vascularized chips provide a controllable, human-relevant microenvironment to evaluate efficacy and safety, bridging the gap between conventional in vitro assays and animal studies.

Service

At Creative Biolabs, we provide a reliable precision immuno-oncology tool that enables rapid, in-depth evaluation of CAR-T cell therapy. Our service moves beyond simple 2D assays to deliver multidimensional data on CAR-T performance within a complex tumor niche, including vascular and stromal components. We provide the clarity needed to demarcate the functional performance of various CAR designs and manufacturing protocols systematically.

What you can expect:

• Customized vascularized chip models tailored to hematological or solid tumor CAR-T programs.
• Functional assessment of CAR-T extravasation, persistence, and tumor engagement.
• Data-driven guidance for CAR design, dosing strategy, and combination evaluation.

Discover How We Can Help - Request a Consultation to design a chip model that meets your specific research needs.

What We Can Offer

Our service offers advanced organ-on-chip platforms, including vascularized tumor models and immune-competent microenvironments, alongside analytical capabilities for real-time imaging, quantitative analysis of tumor killing and immune dynamics, and flexible integration with downstream assays.

Our Workflow

The required starting materials include target CAR-T products; disease-specific cell lines or primary samples; and specific clinical scenarios to model, such as remission or relapse conditions.

The final deliverables include real-time live-cell imaging reports with migration and synaptic data, quantitative cytokine secretion profiles with normalized indices for key cytokines, and a comparative potency analysis matrix for evaluating different car designs or protocols.

Our Advantages

• One-Stop Customization Service: From design and development to analysis, we offer a complete, integrated service for CAR-T studies, ensuring a streamlined process for our clients.
• Proven Expertise in Immunotherapy: Creative Biolabs specializes in immuno-oncology, with a strong focus on CAR-T cell therapies, providing deep insights and cutting-edge technology in the field.
• State-of-the-Art Technology: We use advanced microfluidics and 3D tissue engineering techniques to deliver the most accurate and human-relevant models for CAR-T therapy.
• Rapid Turnaround Time: Our efficient workflow ensures that our clients receive timely results, helping accelerate the drug development process.

Data Support

This research addresses the need for better preclinical testing of CAR-T cell therapies by developing a specialized "leukemia-on-a-chip" model. This device mimics the complex human bone marrow environment, enabling real-time observation of how CAR-T cells infiltrate, activate, and attack cancer cells. The chip successfully models diverse clinical outcomes like remission and relapse, providing a powerful new tool to predict therapeutic success and personalize treatment strategies before human trials.

Fig.1 Fabrication of an organotypic and immunocompetent chip to model the leukaemic bone marrow niche.¹

FAQs

Partner with Us

Creative Biolabs provides a transformative Vascularized Organ-on-Chip Customization Service that accelerates the preclinical development of CAR-T therapies. By bridging the biological gap with human-relevant, spatiotemporal data, we empower you to screen responders and develop optimal therapeutic products with confidence. For detailed project discussions or to receive a technical proposal, please contact us.

Reference

1. Ma, Chao et al. "Bioengineered immunocompetent preclinical trial-on-chip tool enables screening of CAR T cell therapy for leukaemia." Nature biomedical engineering vol. 9,12 (2025): 2098-2114. Distributed under Open Access License CC BY 4.0, without modification. https://doi.org/10.1038/s41551-025-01428-2